# |
PMID |
Sentence |
1 |
15127201
|
In contrast, the reported RAGE ligand S100b was confirmed to induce VCAM-1 expression on endothelial cells and TNF-alpha secretion by PBMCs after 24 h of treatment.
|
2 |
18854308
|
We examined the molecular mechanisms by which the RAGE ligand, S100b, induces COX-2 in monocytes.
|
3 |
18854308
|
S100b significantly increased COX-2 mRNA accumulation in THP-1 monocytes at 2 h via mRNA stability.
|
4 |
18854308
|
Chromatin immunoprecipitation and RNA immunoprecipitation revealed that S100b decreased occupancy of the DNA/RNA-binding protein, heterogeneous nuclear ribonuclear protein K (hnRNPK), at the COX-2 promoter but simultaneously increased its binding to the COX-2 3'-UTR.
|
5 |
18854308
|
S100b treatment promoted the translocation of nuclear hnRNPK to cytoplasm, whereas a cytoplasmic translocation-deficient hnRNPK mutant inhibited S100b-induced COX-2 mRNA stability.
|
6 |
18854308
|
Furthermore, S100b significantly down-regulated the expression of a key microRNA, miR-16, which can destabilize COX-2 mRNA by binding to its 3'-UTR.
|
7 |
20578796
|
SM produced a significant decrease in monocytic interleukin-1? and COX-2 levels and prevented oxidant formation caused by S100b, which appeared to be mediated by inhibition of p47phox membrane translocation.
|